Munjaro is becoming a popular drug for type 1 patients who experience insulin resistance or need help with weight management.
This article explores the use of Munjaro for type 1 diabetes and answers frequently asked questions about this drug.
What is Munjaro?
Mounjaro is the first drug in a class of drugs known as GIP/GLP-1 receptor agonists. It is approved by the FDA to improve blood sugar control in people with type 2 diabetes, along with a healthy diet and exercise.
At this time, only Mounjaro is FDA-approved to manage blood sugar levels in adults with type 2 diabetes.
However, off-label use of medicines is becoming more common.
Why would Type 1 diabetics want to take Munjaro?
Many of Munjaro’s effects may be helpful for people with type 1 diabetes.
This drug makes you feel fuller for longer after meals, which can help you lose weight. It can also help lower glucagon levels, slow digestion, and in some cases reduce blood sugar spikes.
People with type 1 diabetes may benefit from taking Munjaro to help manage their weight as well as improve insulin resistance.
At least one clinical trial is combining a similar drug with an automated insulin delivery system to evaluate whether the combination could help people with type 1 diabetes more easily and consistently maintain healthy blood sugar levels.
Can Munjaro be prescribed to people with type 1 diabetes?
Unlike type 2 diabetes, where insulin resistance is a key feature, the defining feature of type 1 diabetes is the body’s inability to produce insulin.
Because one of Munjaro’s main methods of action is to stimulate the release of insulin from the pancreas, this function is of limited use in patients with type 1 diabetes.
However, this does not mean that this drug is not prescribed to patients with type 1 diabetes.
Like Ozempic (semaglutide), Victoza (liraglutide), and other drugs that have not been specifically studied in people with type 1 diabetes, doctors have begun prescribing Munjaro to people with type 1 diabetes because many of the drug’s effects are so positive.
However, medical professionals would never prescribe drugs like Munjaro in place of insulin therapy for patients with type 1 diabetes. If the drug is prescribed, it is given in addition to traditional insulin therapy.
Munjaro’s effectiveness in improving blood sugar control, reducing the amount of insulin needed, and aiding in weight loss will need to be tested over time through formal clinical trials to assess the drug’s safety, correct dosing, and long-term effectiveness in patients with type 1 diabetes.
The FDA’s approval of Mounjaro clearly states that clinical trials did not include patients with type 1 diabetes and the drug is not approved for use in this population.
If you want to know more about Munjaro, we recommend that you talk to your doctor about the drug and see if it fits into your treatment plan.
What are the side effects of Munjaro if I have type 1 diabetes?
Common side effects of Munjaro include gastrointestinal disturbances such as nausea and diarrhea, loss of appetite and hypoglycemia, especially in insulin users.
More serious but rare side effects may include thyroid tumors, pancreatitis, serious gastrointestinal disturbances, vision changes, gallbladder or kidney problems, and severe allergic reactions.
Users should be aware of these symptoms and seek medical attention if serious side effects occur, as they may pose serious health risks. This is especially important for people with type 1 diabetes who are at increased risk of hypoglycemia.
Is Munjaro prescribed for weight loss?
Munjaro is not approved as a weight loss drug by the U.S. Food and Drug Administration (FDA).
However, the FDA has approved a sister drug for weight loss called Zepbound. Zepbound is the same drug as Mounjaro, but with a different name for use as a weight loss treatment.
Zepbound is approved for use in overweight or obese adults with at least one weight-related condition.
The FDA’s approval of the drug was primarily based on the results of two trials.
See below for more information. Does Munjaro help with weight loss?
Who should not take Munjaro?
Munjaro is not suitable for everyone, including people without diabetes, pregnant or breastfeeding women, and people with a history of certain thyroid cancers or allergies to the ingredients of the drug.
What is the difference between Munharo and Ozempic?
In trials, Munjaro was shown to be effective for weight loss, resulting in slightly greater improvements in average blood sugar levels than Ozempic.
Learn more about how these medicines compare below. Ozempic vs. Munjaro: Which one should you choose?
